Cryo Cell International (CCEL) Proxy filing summary

Executive summary

• Annual Meeting scheduled for October 21, 2025, to elect four directors, ratify auditors, and hold a say-on-pay advisory vote.

• Record date for voting is September 15, 2025, with 8,062,159 shares outstanding.

• Proxy materials and annual report are available online for shareholder review.

Voting matters and shareholder proposals

• Shareholders will vote on electing four directors, ratifying Wipfli LLP as auditors for FY 2025, and approving a non-binding advisory resolution on executive compensation.

• Proposals require a majority of votes cast, except director elections, which are by plurality.

• Procedures for shareholder nominations and proposals for the 2026 meeting are detailed, including deadlines and required disclosures.

Board of directors and corporate governance

• Board consists of four members: David Portnoy, Mark Portnoy, Harold Berger, and Daniel Mizrahi.

• Committees include Audit, Compensation, Governance, and Nominating, all with independent members.

• Board held eight meetings in FY 2024, with all directors attending at least 75% of meetings.

• Independence standards follow NYSE guidelines; Berger and Mizrahi are independent.

• Stockholders can communicate directly with the board and committees.